SYK Stock Recent News

Wall Street analysts rerated Stryker Corp SYK Wednesday after the company's fourth-quarter print.

Wall Street analysts rerated Stryker Corp SYK Wednesday after the company's fourth-quarter print.

SYK announces agreement to sell its U.S. spinal implants business to Viscogliosi Brothers, LLC.

SYK's fourth-quarter results reflect strong segmental performance, along with a rise in operating margin.

Stryker Corporation (NYSE:SYK ) Q4 2024 Earnings Conference Call January 28, 2025 4:30 PM ET Company Participants Kevin Lobo - Chairman, CEO & President Andy Pierce - Group President of MedSurg & Neurotechnology Jason Beach - Vice President, Finance and Investor Relations Glenn Boehnlein - Vice President, Chief Financial Officer Conference Call Participants Lawrence Biegelsen - Wells Fargo Securities Robert Marcus - JPMorgan Travis Steed - Bank of America David Roman - Goldman Sachs Pito Chickering - Deutsche Bank Vijay Kumar - Evercore ISI Matthew O'Brien - Piper Sandler Companies Shagun Singh - RBC Matthew Miksic - Barclays Michael Matson - Needham & Company Caitlin Cronin - Canaccord Genuity Richard Newitter - Truist Securities Josh Jennings - TD Cowen Danielle Antalffy - UBS Equities Michael Polark - Wolfe Research Operator Welcome to the Fourth Quarter 2024 Stryker Earnings Call. My name is Luke, and I'll be your operator for today's call.

Although the revenue and EPS for Stryker (SYK) give a sense of how its business performed in the quarter ended December 2024, it might be worth considering how some key metrics compare with Wall Street estimates and the year-ago numbers.

Stryker (SYK) came out with quarterly earnings of $4.01 per share, beating the Zacks Consensus Estimate of $3.87 per share. This compares to earnings of $3.46 per share a year ago.

Stryker beat Wall Street estimates for fourth-quarter profit and forecast 2025 earnings largely above expectations on Tuesday, fueled by strong demand for its medical and surgical devices.

Stryker Corp. (SYK) ticked higher after hours after the medical tech company posted an earnings beat. George Tsilis turned to how a rally from this mostly unseen stock reflects the healthcare industry.

Portage, Michigan, Jan. 28, 2025 (GLOBE NEWSWIRE) -- Stryker (NYSE:SYK), a global leader in medical technologies, announced today a definitive agreement to sell its U.S. spinal implants business to Viscogliosi Brothers, LLC, a family-owned investment firm specializing in the neuro-musculoskeletal space, to create a newly formed company called VB Spine, LLC.